As one of the fastest-growing pharmaceutical company in Türkiye, we have been providing solutions worldwide for rare diseases and unmet medical needs since 1998. With our vast range of products, innovative approach, and global team of experts, we continue our efforts within the framework of ethical and scientific principles, aiming to be a significant global player in the pharmaceutical industry and the health brand of the future.
100% Local and
Publicly Traded Company
10 Offices in
7 Countries
25+ Years of Experience in
Rare Diseases
GMP-Certified Manufacturing
Facility and Center
Investor Relations
22.62% of our company was offered to the public at 10.75 TL on August 5, 2021, following high interest and demand from our investors.
GEN shares are traded on Borsa Istanbul (BIST) under the ticker “GENİL” and have continued their steady rise since the day they were offered.
Investor Relations
22.62% of our company was offered to the public at 10.75 TL on August 5, 2021, following high interest and demand from our investors.
GEN shares are traded on Borsa Istanbul (BIST) under the ticker “GENİL” and have continued their steady rise since the day they were offered.
Our Solutions
GEN, with its versatile business model, provides solutions for rare diseases and unmet medical needs worldwide through strong global partnerships.
Additionally, with its state-of-the-art manufacturing facility meeting the highest standards and substantial R&D investments, GEN develops and produces highly demanded and competitive products for the international market.
We Care About Ethics and Compliance
You can send your complaints and feedback to us anonymously. You can click the icon for Ethics and Compliance Feedback form.
Adverse Reaction
Notification
If you want to report adverse reactions related to our products, you can fill in TÜFAM Adverse Reaction Notification Form and send it to [email protected]
Adverse Reaction Notification
If you want to report adverse reactions related to our products, you can fill in TÜFAM Adverse Reaction Notification Form and send it to [email protected]